Tag Archive | "MorphoSys"

Morphosys acquires Lanthio Pharma

Tags: ,


MorphoSys has acquired all outstanding shares of the Dutch biopharmaceutical company Lanthio Pharma B.V. Read the full story

Morphosys acquires lanthipeptide technology from Lanthio Pharma

Tags: , , , ,


MorphoSys and Lanthio Pharma acquires of Lanthio Pharma's lanthipeptide technology, which will be used for drug discovery by MorphoSys. Read the full story

Partnering Agreements with Morphosys

Tags: ,


The Partnering Agreements with Morphosys report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies. Read the full story

MorphoSys: Partnering activity 2009-2014

Tags: , ,


MorphoSys, a leader in antibody drug discovery, has emerged as a top 50 big biotech company with its product pipeline and partnering strategy. Read the full story

MorphoSys M&A deals 2009-2014

Tags: ,


MorphoSys has announced only one acquisition in the past 5 years. Read the full story

Morphosys: Clear leaders in antibody generation

Tags: , , ,


Morphosys is a leading biotechnology developing therapeutic antibodies for a range of different indications. Read the full story

MorphoSys and Celgene pharma deals for Oncology drug co-development and co-marketing in $818 million deal

Tags: , , ,


MorphoSys, a big pharma, and Celgene, a big pharma and big biotech, announced pharma deals to jointly develop MOR202 globally and to co-promote MOR202 in Europe. Read the full story

MorphoSys: Company profile

Tags:


Read the full story